-
1
-
-
13844318259
-
The role of anticholinergics in chronic obstructive pulmonary disease
-
Barnes PJ. The role of anticholinergics in chronic obstructive pulmonary disease. Am J Med. 2004;117(Suppl 12A):24S-32S.
-
(2004)
Am J Med
, vol.117
, Issue.SUPPL. 12A
-
-
Barnes, P.J.1
-
2
-
-
53749102775
-
UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease
-
Tashkin DP, Celli B, Senn S, et al; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359( 15 ):1543-1554.
-
(2008)
N Engl J Med
, vol.359
, Issue.15
, pp. 1543-1554
-
-
Tashkin, D.P.1
Celli, B.2
Senn, S.3
-
3
-
-
0036683267
-
Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study
-
Anthonisen NR, Connett JE, Enright PL, Manfreda J; Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med. 2002;166( 3 ):333-339.
-
(2002)
Am J Respir Crit Care Med
, vol.166
, Issue.3
, pp. 333-339
-
-
Anthonisen, N.R.1
Connett, J.E.2
Enright, P.L.3
Manfreda, J.4
-
4
-
-
0033025322
-
Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma
-
Guite HF, Dundas R, Burney PG. Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma. Thorax. 1999;54( 4 ):301-307.
-
(1999)
Thorax
, vol.54
, Issue.4
, pp. 301-307
-
-
Guite, H.F.1
Dundas, R.2
Burney, P.G.3
-
5
-
-
51949090107
-
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease
-
Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB. Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease. Ann Intern Med. 2008;149( 6 ):380-390.
-
(2008)
Ann Intern Med
, vol.149
, Issue.6
, pp. 380-390
-
-
Lee, T.A.1
Pickard, A.S.2
Au, D.H.3
Bartle, B.4
Weiss, K.B.5
-
6
-
-
42149094428
-
Cardiovascular morbidity and the use of inhaled bronchodilators
-
Macie C, Wooldrage K, Manfreda J, Anthonisen N. Cardiovascular morbidity and the use of inhaled bronchodilators. Int J Chron Obstruct Pulmon Dis. 2008;3( 1 ):163-169.
-
(2008)
Int J Chron Obstruct Pulmon Dis
, vol.3
, Issue.1
, pp. 163-169
-
-
Macie, C.1
Wooldrage, K.2
Manfreda, J.3
Anthonisen, N.4
-
7
-
-
52449106502
-
Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
-
Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008;300( 12 ):1439-1450.
-
(2008)
JAMA
, vol.300
, Issue.12
, pp. 1439-1450
-
-
Singh, S.1
Loke, Y.K.2
Furberg, C.D.3
-
8
-
-
0346101503
-
Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: Time-dependent analysis
-
Fan VS, Bryson CL, Curtis JR, et al. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis. Am J Respir Crit Care Med. 2003;168( 12 ):1488-1494.
-
(2003)
Am J Respir Crit Care Med
, vol.168
, Issue.12
, pp. 1488-1494
-
-
Fan, V.S.1
Bryson, C.L.2
Curtis, J.R.3
-
9
-
-
33745126270
-
Spirometry use in clinical practice following diagnosis of COPD
-
Lee TA, Bartle B, Weiss KB. Spirometry use in clinical practice following diagnosis of COPD. Chest. 2006;129( 6 ):1509-1515.
-
(2006)
Chest
, vol.129
, Issue.6
, pp. 1509-1515
-
-
Lee, T.A.1
Bartle, B.2
Weiss, K.B.3
-
10
-
-
32644435902
-
COPD exacerbations. 1: Epidemiology
-
Donaldson GC, Wedzicha JA. COPD exacerbations. 1: Epidemiology . Thorax. 2006;61( 2 ):164-168.
-
(2006)
Thorax
, vol.61
, Issue.2
, pp. 164-168
-
-
Donaldson, G.C.1
Wedzicha, J.A.2
-
11
-
-
0033046689
-
Time-dependent covariates in the Cox proportional-hazards regression model
-
Fisher LD, Lin DY. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health. 1999; 20:145-157.
-
(1999)
Annu Rev Public Health
, vol.20
, pp. 145-157
-
-
Fisher, L.D.1
Lin, D.Y.2
-
12
-
-
0037370244
-
Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma?
-
Ringbaek T, Viskum K. Is there any association between inhaled ipratropium and mortality in patients with COPD and asthma? Respir Med. 2003;97( 3 ):264-272.
-
(2003)
Respir Med
, vol.97
, Issue.3
, pp. 264-272
-
-
Ringbaek, T.1
Viskum, K.2
-
13
-
-
33748369326
-
Meta-analysis: Anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD
-
Salpeter SR, Buckley NS, Salpeter EE. Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD. J Gen Intern Med. 2006;21( 10 ):1011-1019.
-
(2006)
J Gen Intern Med
, vol.21
, Issue.10
, pp. 1011-1019
-
-
Salpeter, S.R.1
Buckley, N.S.2
Salpeter, E.E.3
-
14
-
-
33847224191
-
Veterans' access to and use of Medicare and Veterans Affairs health care
-
Hynes DM, Koelling K, Stroupe K, et al. Veterans' access to and use of Medicare and Veterans Affairs health care. Med Care. 2007;45( 3 ):214-223.
-
(2007)
Med Care
, vol.45
, Issue.3
, pp. 214-223
-
-
Hynes, D.M.1
Koelling, K.2
Stroupe, K.3
|